Viyash Scientific Ltd is Rated Hold by MarketsMOJO

Understanding the Current Rating

The 'Hold' rating assigned to Viyash Scientific Ltd indicates a balanced view of the stock’s prospects. It suggests that investors should maintain their existing positions rather than aggressively buying or selling at this stage. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment appeal in the Pharmaceuticals & Biotechnology sector.

Quality Assessment

As of 17 July 2026, Viyash Scientific’s quality grade is considered below average. This is primarily due to its weak long-term fundamental strength, with an average Return on Capital Employed (ROCE) of just 5.81%. While the company has demonstrated an operating profit growth rate of 18.70% annually over the past five years, this growth is modest relative to industry peers. The below-average quality grade reflects concerns about the sustainability of earnings and the company’s ability to generate consistent returns on invested capital over the long term.

Valuation Perspective

The stock’s valuation is currently classified as expensive. Viyash Scientific trades at a Price to Book (P/B) ratio of 4.2, which is high compared to its own historical averages and some peers in the sector. Despite this, the stock is trading at a discount relative to the average historical valuations of its peer group, suggesting some relative value remains. The company’s Return on Equity (ROE) stands at 6.5%, which, combined with a Price/Earnings to Growth (PEG) ratio of 1.2, indicates that the market is pricing in moderate growth expectations. Investors should weigh the premium valuation against the company’s growth prospects and profitability metrics.

Financial Trend and Performance

Financially, Viyash Scientific Ltd shows an outstanding grade, reflecting strong recent performance and improving fundamentals. As of 17 July 2026, the company has reported a remarkable 539.5% growth in net profit, with the latest quarterly PAT reaching ₹52.11 crores, representing a 446.4% increase. Operating profit to interest coverage ratio is robust at 12.69 times, indicating strong earnings relative to debt servicing costs. The debt-equity ratio remains low at 0.17 times, underscoring a conservative capital structure. The company has declared positive results for nine consecutive quarters, signalling consistent operational momentum.

In terms of returns, the stock has delivered impressive gains over various time frames. The one-year return stands at 41.81%, outperforming the BSE500 index in each of the last three annual periods. Year-to-date returns are also strong at 28.97%, with six-month and three-month returns at 38.66% and 28.51%, respectively. This consistent performance highlights the company’s ability to generate shareholder value despite some fundamental challenges.

Technical Outlook

Technically, Viyash Scientific Ltd is rated bullish. The stock’s recent price action supports a positive momentum trend, although it experienced a 3.00% decline on the day of analysis (17 July 2026). The bullish technical grade suggests that the stock may continue to attract buying interest in the near term, supported by strong financial results and improving market sentiment. However, investors should remain cautious given the stock’s valuation and quality concerns.

Shareholding and Market Capitalisation

Viyash Scientific Ltd is classified as a small-cap company within the Pharmaceuticals & Biotechnology sector. Promoters remain the majority shareholders, which often provides stability in corporate governance and strategic direction. The company’s market capitalisation and sector positioning should be considered by investors when assessing risk and growth potential.

What the Hold Rating Means for Investors

The 'Hold' rating on Viyash Scientific Ltd advises investors to maintain their current holdings rather than initiating new positions or exiting existing ones. This recommendation reflects a balanced risk-reward profile. While the company’s recent financial performance and technical momentum are encouraging, the below-average quality and expensive valuation temper enthusiasm. Investors should monitor upcoming quarterly results and sector developments closely to reassess the stock’s outlook.

For those considering entry, the stock’s bullish technical grade and strong recent returns may offer opportunities, but the premium valuation and moderate return on capital suggest caution. Long-term investors should focus on the company’s ability to sustain profit growth and improve fundamental quality metrics before increasing exposure.

Summary of Key Metrics as of 17 July 2026

- Mojo Score: 63.0 (Hold Grade)
- 1-Year Return: +41.81%
- ROCE: 5.81% (Below Average Quality)
- Net Profit Growth (Latest Quarter): 539.5%
- Debt-Equity Ratio: 0.17 (Low Leverage)
- Price to Book Value: 4.2 (Expensive Valuation)
- Technical Grade: Bullish

In conclusion, Viyash Scientific Ltd’s current 'Hold' rating by MarketsMOJO reflects a nuanced view of the company’s prospects. Investors are encouraged to consider both the strong financial momentum and the valuation and quality concerns when making portfolio decisions. Staying informed on the company’s quarterly performance and sector trends will be essential for navigating the stock’s future trajectory.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →